Bay K8644: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 21: | Line 21: | ||
[[Category:Calcium channel agonists]] | [[Category:Calcium channel agonists]] | ||
{{pharma-stub}} | {{pharma-stub}} | ||
== Bay_K8644 == | |||
<gallery> | |||
File:Bay_K8644_structure.svg|Bay K8644 structure | |||
File:Bay-K8644-3D-spacefill.png|Bay K8644 3D spacefill | |||
</gallery> | |||
Latest revision as of 20:56, 25 February 2025
Bay K8644 is a pharmacological agent that acts as a calcium channel agonist. It is often used in scientific research to study the function of calcium channels in cells.
Mechanism of Action[edit]
Bay K8644 works by binding to the L-type calcium channel on the cell membrane. This binding increases the channel's sensitivity to calcium, causing it to open more frequently and for longer periods of time. As a result, more calcium ions are able to enter the cell, which can trigger various cellular processes.
Uses in Research[edit]
Due to its ability to modulate calcium channel activity, Bay K8644 is often used in neuroscience and cardiology research. For example, it can be used to study the role of calcium channels in neuronal signaling and cardiac muscle contraction.
Pharmacokinetics[edit]
Like many other pharmacological agents, the effects of Bay K8644 are dose-dependent. It is typically administered in vitro, and its effects can be observed within minutes of application.
Side Effects[edit]
While Bay K8644 is generally safe for use in research settings, it can have side effects if used inappropriately. These can include cell death due to excessive calcium influx, as well as potential effects on heart rate and blood pressure.
See Also[edit]
Bay_K8644[edit]
-
Bay K8644 structure
-
Bay K8644 3D spacefill
